Assembly Biosciences, INC. (ASMB) SEC Filings — 2024
18 SEC filings for Assembly Biosciences, INC. (ASMB) in 2024.
Filings
- Assembly Biosciences Files 8-K — 8-K · Dec 26, 2024
- Assembly Biosciences Files 8-K on Material Agreement — 8-K · Dec 19, 2024
- Assembly Biosciences Files 8-K with Corporate Updates — 8-K · Dec 13, 2024
- Assembly Biosciences, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Assembly Biosciences Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
- Assembly Biosciences Files 8-K — 8-K · Sep 23, 2024
- Assembly Biosciences Q2 2024: Cash Down, Arbutus Deal Details — 10-Q · Aug 8, 2024
- Schornstein Amends Stake in Assembly Biosciences — SC 13D/A · Jun 24, 2024
- Gilead Sciences Amends Filing for Assembly Biosciences Stake — SC 13D/A · Jun 20, 2024
- Assembly Biosciences Enters Material Agreement — 8-K · Jun 18, 2024
- Assembly Biosciences Ditches HBV Program, Cuts 45% Workforce — 8-K · Jun 3, 2024
- Assembly Biosciences, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
- Assembly Biosciences, Inc. Files Definitive Proxy Statement (DEF 14A) — DEF 14A · Apr 17, 2024
- Assembly Biosciences Files 8-K on Operations — 8-K · Mar 28, 2024
- Assembly Biosciences Appoints New CEO, CMO, CFO — 8-K · Mar 15, 2024
- Assembly Biosciences Reports Bylaw & Security Holder Rights Changes — 8-K · Feb 13, 2024
- ASMB Files 8-K on Shareholder Vote & Other Events — 8-K · Feb 2, 2024
- ASMB Terminates Material Agreement, Signals Strategic Shift — 8-K · Jan 17, 2024